<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33184465</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5403</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Cell death and differentiation</Title><ISOAbbreviation>Cell Death Differ</ISOAbbreviation></Journal><ArticleTitle>ALS motor neurons exhibit hallmark metabolic defects that are rescued by SIRT3 activation.</ArticleTitle><Pagination><StartPage>1379</StartPage><EndPage>1397</EndPage><MedlinePgn>1379-1397</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41418-020-00664-0</ELocationID><Abstract><AbstractText>Motor neurons (MNs) are highly energetic cells and recent studies suggest that altered energy metabolism precede MN loss in amyotrophic lateral sclerosis (ALS), an age-onset neurodegenerative disease. However, clear mechanistic insights linking altered metabolism and MN death are still missing. In this study, induced pluripotent stem cells from healthy controls, familial ALS, and sporadic ALS patients were differentiated toward spinal MNs, cortical neurons, and cardiomyocytes. Metabolic flux analyses reveal an MN-specific deficiency in mitochondrial respiration in ALS. Intriguingly, all forms of familial and sporadic ALS MNs tested in our study exhibited similar defective metabolic profiles, which were attributed to hyper-acetylation of mitochondrial proteins. In the mitochondria, Sirtuin-3 (SIRT3) functions as a mitochondrial deacetylase to maintain mitochondrial function and integrity. We found that activating SIRT3 using nicotinamide or a small molecule activator reversed the defective metabolic profiles in all our ALS MNs, as well as correct a constellation of ALS-associated phenotypes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hor</LastName><ForeName>Jin-Hui</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore, 138673, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, National University of Singapore, Singapore, 117543, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santosa</LastName><ForeName>Munirah Mohamad</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore, 138673, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine (Physiology), National University of Singapore, Singapore, 117456, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Valerie Jing Wen</ForeName><Initials>VJW</Initials><AffiliationInfo><Affiliation>Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore, 138673, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Beatrice Xuan</ForeName><Initials>BX</Initials><AffiliationInfo><Affiliation>Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore, 138673, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, National University of Singapore, Singapore, 117543, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khong</LastName><ForeName>Zi Jian</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore, 138673, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biological Sciences, Nanyang Technological University, Singapore, 637551, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravits</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liou</LastName><ForeName>Yih-Cherng</ForeName><Initials>YC</Initials><Identifier Source="ORCID">0000-0003-0149-6856</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, National University of Singapore, Singapore, 117543, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soh</LastName><ForeName>Boon-Seng</ForeName><Initials>BS</Initials><Identifier Source="ORCID">0000-0001-9134-3081</Identifier><AffiliationInfo><Affiliation>Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore, 138673, Singapore. bssoh@imcb.a-star.edu.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, National University of Singapore, Singapore, 117543, Singapore. bssoh@imcb.a-star.edu.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China. bssoh@imcb.a-star.edu.sg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Shi-Yan</ForeName><Initials>SY</Initials><Identifier Source="ORCID">0000-0003-3418-2757</Identifier><AffiliationInfo><Affiliation>Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore, 138673, Singapore. syng@imcb.a-star.edu.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine (Physiology), National University of Singapore, Singapore, 117456, Singapore. syng@imcb.a-star.edu.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China. syng@imcb.a-star.edu.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Neuroscience Institute, Singapore, 308433, Singapore. syng@imcb.a-star.edu.sg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NRF-NRFF-2018-003</GrantID><Agency>National Research Foundation Singapore (National Research Foundation-Prime Minister's office, Republic of Singapore)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Differ</MedlineTA><NlmUniqueID>9437445</NlmUniqueID><ISSNLinking>1350-9047</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.5.1.-</RegistryNumber><NameOfSubstance UI="C466093">SIRT3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.1.-</RegistryNumber><NameOfSubstance UI="D056566">Sirtuin 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056566" MajorTopicYN="N">Sirtuin 3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>13</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33184465</ArticleId><ArticleId IdType="pmc">PMC8027637</ArticleId><ArticleId IdType="doi">10.1038/s41418-020-00664-0</ArticleId><ArticleId IdType="pii">10.1038/s41418-020-00664-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:75&#x2013;82. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC, Treleaven CM, Fidler JA, Tamsett TJ, Bao C, Searles M, et al. Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis. Proc Natl Acad Sci USA. 2013;110:10812&#x2013;7. doi: 10.1073/pnas.1308421110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1308421110</ArticleId><ArticleId IdType="pmc">PMC3696768</ArticleId><ArticleId IdType="pubmed">23754387</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Iwata M. Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2007;66:10&#x2013;6. doi: 10.1097/nen.0b013e31802c396b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e31802c396b</ArticleId><ArticleId IdType="pubmed">17204932</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Warita H, Murakami T, Abe K, Iwata M. Ultrastructural study of mitochondria in the spinal cord of transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol. 2004;107:461&#x2013;74. doi: 10.1007/s00401-004-0837-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-004-0837-z</ArticleId><ArticleId IdType="pubmed">15029445</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D, Rognoni F, van Duijn W, Verspaget HW, Haasdijk ED, Holstege JC. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations. Acta Neuropathol. 2001;102:293&#x2013;305. doi: 10.1007/s004010100399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010100399</ArticleId><ArticleId IdType="pubmed">11603803</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiazzi M, D&#x2019;Aurelio M, Gajewski CD, Martushova K, Kiaei M, Beal MF, et al. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem. 2002;277:29626&#x2013;33. doi: 10.1074/jbc.M203065200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M203065200</ArticleId><ArticleId IdType="pubmed">12050154</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SP, Duffy LM, Shaw PJ, Grierson AJ. Altered age-related changes in bioenergetic properties and mitochondrial morphology in fibroblasts from sporadic amyotrophic lateral sclerosis patients. Neurobiol Aging. 2015;36:2893&#x2013;903. doi: 10.1016/j.neurobiolaging.2015.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.07.013</ArticleId><ArticleId IdType="pubmed">26344876</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Boyer L, Jin M, Mertens J, Ma L, et al. Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation. Elife. 2016;5:e13374. doi: 10.7554/eLife.13374.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.13374</ArticleId><ArticleId IdType="pmc">PMC4963198</ArticleId><ArticleId IdType="pubmed">27282387</ArticleId></ArticleIdList></Reference><Reference><Citation>Breuer ME, Koopman WJ, Koene S, Nooteboom M, Rodenburg RJ, Willems PH, et al. The role of mitochondrial OXPHOS dysfunction in the development of neurologic diseases. Neurobiol Dis. 2013;51:27&#x2013;34. doi: 10.1016/j.nbd.2012.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.03.007</ArticleId><ArticleId IdType="pubmed">22426394</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulting GL, Kiskinis E, Croft GF, Amoroso MW, Oakley DH, Wainger BJ, et al. A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol. 2011;29:279&#x2013;86. doi: 10.1038/nbt.1783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1783</ArticleId><ArticleId IdType="pmc">PMC3229307</ArticleId><ArticleId IdType="pubmed">21293464</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, Sandoe J, Williams LA, Boulting GL, Moccia R, Wainger BJ, et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell. 2014;14:781&#x2013;95. doi: 10.1016/j.stem.2014.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.03.004</ArticleId><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Geller HM, Cheng KY, Goldsmith NK, Romero AA, Zhang AL, Morris EJ, et al. Oxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside. J Neurochem. 2001;78:265&#x2013;75. doi: 10.1046/j.1471-4159.2001.00395.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2001.00395.x</ArticleId><ArticleId IdType="pubmed">11461962</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A, et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci USA. 2008;105:14447&#x2013;52. doi: 10.1073/pnas.0803790105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0803790105</ArticleId><ArticleId IdType="pmc">PMC2567183</ArticleId><ArticleId IdType="pubmed">18794531</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol. 2007;27:8807&#x2013;14. doi: 10.1128/MCB.01636-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01636-07</ArticleId><ArticleId IdType="pmc">PMC2169418</ArticleId><ArticleId IdType="pubmed">17923681</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao R, Vassilopoulos A, Parisiadou L, Yan Y, Gius D. Regulation of MnSOD enzymatic activity by Sirt3 connects the mitochondrial acetylome signaling networks to aging and carcinogenesis. Antioxid Redox Signal. 2014;20:1646&#x2013;54. doi: 10.1089/ars.2013.5482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5482</ArticleId><ArticleId IdType="pmc">PMC3942696</ArticleId><ArticleId IdType="pubmed">23886445</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Zhang H, Chen X, Zou Y, Li J, Wang L, et al. A small molecule activator of SIRT3 promotes deacetylation and activation of manganese superoxide dismutase. Free Radic Biol Med. 2017;112:287&#x2013;97. doi: 10.1016/j.freeradbiomed.2017.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2017.07.012</ArticleId><ArticleId IdType="pubmed">28711502</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Nagasawa K, Munch C, Xu Y, Satterstrom K, Jeong S, et al. Mitochondrial sirtuin network reveals dynamic SIRT3-dependent deacetylation in response to membrane depolarization. Cell. 2016;167:985&#x2013;1000.e21. doi: 10.1016/j.cell.2016.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC5134900</ArticleId><ArticleId IdType="pubmed">27881304</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, Kiskinis E, Mellin C, Wiskow O, Han SS, Sandoe J, et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 2014;7:1&#x2013;11. doi: 10.1016/j.celrep.2014.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.03.019</ArticleId><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundback T, Nordlund P, et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc. 2014;9:2100&#x2013;22. doi: 10.1038/nprot.2014.138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2014.138</ArticleId><ArticleId IdType="pubmed">25101824</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasmann M, Schemainda I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res. 2003;63:7436&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">14612543</ArticleId></ArticleIdList></Reference><Reference><Citation>Su XW, Broach JR, Connor JR, Gerhard GS, Simmons Z. Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research. Muscle Nerve. 2014;49:786&#x2013;803. doi: 10.1002/mus.24198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24198</ArticleId><ArticleId IdType="pubmed">24488689</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann FR, Manfredi G, Mawrin C, Beal MF, Schon EA. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J Neurochem. 2002;80:616&#x2013;25. doi: 10.1046/j.0022-3042.2001.00731.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0022-3042.2001.00731.x</ArticleId><ArticleId IdType="pubmed">11841569</ArticleId></ArticleIdList></Reference><Reference><Citation>Borthwick GM, Johnson MA, Ince PG, Shaw PJ, Turnbull DM. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol. 1999;46:787&#x2013;90. doi: 10.1002/1531-8249(199911)46:5&lt;787::AID-ANA17&gt;3.0.CO;2-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(199911)46:5&lt;787::AID-ANA17&gt;3.0.CO;2-8</ArticleId><ArticleId IdType="pubmed">10553999</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Kim S, Choi JE, Han D, Koh SM, Kim HS, et al. Decreased neuron number and synaptic plasticity in SIRT3-knockout mice with poor remote memory. Neurochem Res. 2019;44:676&#x2013;82. doi: 10.1007/s11064-017-2417-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-017-2417-3</ArticleId><ArticleId IdType="pubmed">29076061</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng A, Yang Y, Zhou Y, Maharana C, Lu D, Peng W, et al. Mitochondrial SIRT3 mediates adaptive responses of neurons to exercise and metabolic and excitatory challenges. Cell Metab. 2016;23:128&#x2013;42. doi: 10.1016/j.cmet.2015.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.10.013</ArticleId><ArticleId IdType="pmc">PMC5141613</ArticleId><ArticleId IdType="pubmed">26698917</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Rubia JE, Drehmer E, Platero JL, Benlloch M, Caplliure-Llopis J, Villaron-Casales C, et al. Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:115&#x2013;22. doi: 10.1080/21678421.2018.1536152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1536152</ArticleId><ArticleId IdType="pubmed">30668199</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhang Q, Bao R, Zhang N, Wang Y, Polo-Parada L, et al. Deletion oF Nampt in Projection Neurons of Adult Mice Leads to Motor Dysfunction, Neurodegeneration, and Death. Cell Rep. 2017;20:2184&#x2013;200. doi: 10.1016/j.celrep.2017.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.08.022</ArticleId><ArticleId IdType="pmc">PMC6021762</ArticleId><ArticleId IdType="pubmed">28854367</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlan BA, Killoy KM, Pehar M, Liu L, Auwerx J, Vargas MR. Evaluation of the NAD(+) biosynthetic pathway in ALS patients and effect of modulating NAD(+) levels in hSOD1-linked ALS mouse models. Exp Neurol. 2020;327:113219. doi: 10.1016/j.expneurol.2020.113219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113219</ArticleId><ArticleId IdType="pmc">PMC7089832</ArticleId><ArticleId IdType="pubmed">32014438</ArticleId></ArticleIdList></Reference><Reference><Citation>Camacho-Pereira J, Tarrago MG, Chini CCS, Nin V, Escande C, Warner GM, et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 2016;23:1127&#x2013;39. doi: 10.1016/j.cmet.2016.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2016.05.006</ArticleId><ArticleId IdType="pmc">PMC4911708</ArticleId><ArticleId IdType="pubmed">27304511</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. Eur J Neurol. 2007;14:262&#x2013;8. doi: 10.1111/j.1468-1331.2006.01575.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2006.01575.x</ArticleId><ArticleId IdType="pubmed">17355545</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing G, Edaravone ALSSG. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Hor JH, Soh ES, Tan LY, Lim VJW, Santosa MM, Winanto, et al. Cell cycle inhibitors protect motor neurons in an organoid model of spinal muscular atrophy. Cell Death Dis. 2018;9:1100.. doi: 10.1038/s41419-018-1081-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-1081-0</ArticleId><ArticleId IdType="pmc">PMC6204135</ArticleId><ArticleId IdType="pubmed">30368521</ArticleId></ArticleIdList></Reference><Reference><Citation>Muratore CR, Srikanth P, Callahan DG, Young-Pearse TL. Comparison and optimization of hiPSC forebrain cortical differentiation protocols. PLoS ONE. 2014;9:e105807. doi: 10.1371/journal.pone.0105807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105807</ArticleId><ArticleId IdType="pmc">PMC4148335</ArticleId><ArticleId IdType="pubmed">25165848</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat Protoc. 2013;8:162&#x2013;75. doi: 10.1038/nprot.2012.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2012.150</ArticleId><ArticleId IdType="pmc">PMC3612968</ArticleId><ArticleId IdType="pubmed">23257984</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperling S, Aung T, Martin S, Rohde V, Ninkovic M. Riluzole: a potential therapeutic intervention in human brain tumor stem-like cells. Oncotarget. 2017;8:96697&#x2013;709. doi: 10.18632/oncotarget.18043.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.18043</ArticleId><ArticleId IdType="pmc">PMC5722515</ArticleId><ArticleId IdType="pubmed">29228563</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BJ, Egi Y, van Leyen K, Lo EH, Arai K. Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro. Brain Res. 2010;1307:22&#x2013;7. doi: 10.1016/j.brainres.2009.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.10.026</ArticleId><ArticleId IdType="pmc">PMC2797401</ArticleId><ArticleId IdType="pubmed">19840779</ArticleId></ArticleIdList></Reference><Reference><Citation>Schondorf DC, Ivanyuk D, Baden P, Sanchez-Martinez A, De Cicco S, Yu C, et al. The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and Fly models of Parkinson&#x2019;s disease. Cell Rep. 2018;23:2976&#x2013;88. doi: 10.1016/j.celrep.2018.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.05.009</ArticleId><ArticleId IdType="pubmed">29874584</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>